| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,406,023 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,406,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,166 |
174,658 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2021-02-10 |
4 |
D |
$38.85 |
$87,024 |
D/D |
(2,240) |
239,396 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,269 |
77,121 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,270 |
58,317 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-27 |
4 |
D |
$7.33 |
$17,130 |
D/D |
(2,337) |
74,852 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2022-01-01 |
4 |
D |
$42.48 |
$99,658 |
D/D |
(2,346) |
171,406 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2013-02-12 |
4 |
D |
$7.59 |
$17,966 |
D/D |
(2,367) |
68,298 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,389 |
173,099 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2014-02-27 |
4 |
D |
$13.30 |
$31,854 |
D/D |
(2,395) |
97,556 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-27 |
4 |
D |
$16.90 |
$40,476 |
D/D |
(2,395) |
131,007 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-28 |
4 |
D |
$27.26 |
$67,768 |
D/D |
(2,486) |
232,363 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,675 |
128,038 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,676 |
171,716 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,676 |
231,164 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,676 |
256,675 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-01 |
4 |
D |
$45.22 |
$132,269 |
D/D |
(2,925) |
260,219 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-28 |
4 |
D |
$17.21 |
$50,787 |
D/D |
(2,951) |
174,738 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-15 |
4 |
AS |
$35.46 |
$107,727 |
D/D |
(3,038) |
240,168 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-01-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
243,206 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-03-15 |
4 |
AS |
$40.11 |
$121,854 |
D/D |
(3,038) |
254,469 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-03-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
257,507 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-05-15 |
4 |
AS |
$36.74 |
$111,616 |
D/D |
(3,038) |
254,469 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-05-15 |
4 |
OE |
$7.41 |
$22,512 |
D/D |
3,038 |
257,507 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-15 |
4 |
AS |
$40.32 |
$122,532 |
D/D |
(3,039) |
241,254 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-04-15 |
4 |
OE |
$7.41 |
$22,519 |
D/D |
3,039 |
257,508 |
0 |
- |
|
176 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
